-
Views
-
Cite
Cite
ROGER CLAYTON, A double‐blind trial of 0.05% clobetasol proprionate in the treatment of vitiligo, British Journal of Dermatology, Volume 96, Issue 1, 1 January 1977, Pages 71–73, https://doi.org/10.1111/j.1365-2133.1977.tb05188.x
Close - Share Icon Share
SUMMARY
0.05% clobetasol proprionate (CP) in its proprietary cream base was significantly superior to the cream base alone in the treatment of vitiligo. Twelve of twenty‐three patients partially repigmented during 4 months' treatment with CP. All patients showed dermal atrophy with the CP.
This content is only available as a PDF.
© 1977 British Association of Dermatologists
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
Issue Section:
Pharmacology and Treatment
You do not currently have access to this article.
